DarioHealth Corp.

For the period ended Mar 31, 2026. Filed May 13, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 13, 2026

DRIO$2.38-12.8%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Interim Statements of Comprehensive Loss (Unaudited)


· · Three months ended
· · March 31,
· · 2026 · · 2025
Revenues:
Services	$2,826	$4,875
Consumer hardware	2,758	1,877
Total revenues	5,584	6,752

Cost of revenues:
Services	563	865
Consumer hardware	1,644	1,130
Amortization of acquired intangible assets	177	875
Total cost of revenues	2,384	2,870

Gross profit	3,200	3,882

Operating expenses:
Research and development	$2,385	$4,108
Sales and marketing	4,898	5,873
General and administrative	3,226	3,310

Total operating expenses	10,509	13,291

Operating loss	7,309	9,409

Interest expenses	1,149	—
Other financial income, net	(266)	(204)

Total financial expenses (income), net	883	(204)

Loss before taxes	8,192	9,205

Income tax (benefit)	57	22

Net loss	$8,249	$9,227

Deemed dividend	$—	$4,839

Net loss attributable to common shareholders	$8,249	$14,066

Net loss per share:

Basic and diluted loss per share of common stock	$1.25	$2.87
Weighted average number of common stock used in computing basic and diluted net loss per share**	6,582,297	2,368,516

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.